Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QLD vs MRNA✓SelectedUSD · MRNAQLD vs MRNA performance historyLatest closeAs of-10.86%11/20
Stock and ETF performance explorer

QLD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+598.0%
MRNA return
+786.4%
Excess return
-188.4%
Maximum drawdown
-63.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.9%-2.2%-8.7%-10.7%
7D-19.9%-12.7%-7.2%-18.8%
30D-30.5%-20.7%-9.9%-29.1%
3M-28.6%+46.3%-74.8%-31.4%
6M-30.9%+305.2%-336.2%-46.4%
YTD-9.7%+561.2%-570.9%-36.2%
1Y-1.2%+772.1%-773.3%-33.6%
3Y+83.9%+147.0%-63.1%+43.4%
5Y+39.3%-26.1%+65.3%+22.8%
All+598.0%+786.4%-188.4%+379.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling